Systemically injected exosomes targeted to EGFR deliver antitumor microrna to breast cancer cells

Molecular Therapy

Volumn 21, Issue 1, 2013, Pages 185-191

  Ohno, Shin Ichiro ^a   Takanashi, Masakatsu ^a   Sudo, Katsuko ^a   Ueda, Shinobu ^a   Ishikawa, Akio ^a   Matsuyama, Nagahisa ^a   Fujita, Koji ^a   Mizutani, Takayuki ^a   Ohgi, Tadaaki ^b   Ochiya, Takahiro ^c   Gotoh, Noriko ^d   Kuroda, Masahiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b BONAC Corporation   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; EPIDERMAL GROWTH FACTOR RECEPTOR; GE11 PEPTIDE; MICRORNA; PEPTIDE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CONTROLLED STUDY; EXOSOME; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SURFACE PROPERTY;

MUS;

EID: 84871923602     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.180     Document Type: Article

References (21)

1. Bartel, DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell116: 281-297.
2. Calin, GA and Croce, CM (2006). MicroRNA signatures in human cancers. Nat RevCancer 6: 857-866. (Pubitemid 44629897)
3. Barh, D, Malhotra, R, Ravi, B and Sindhurani, P (2010). MicroRNA let-7: an emergingnext-generation cancer therapeutic. Curr Oncol 17: 70-80.
4. Lotvall, J and Valadi, H (2007). Cell to cell signalling via exosomes through esRNA.Cell Adh Migr 1: 156-158.
5. Skog, J, W?dinger, T, van Rijn, S, Meijer, DH, Gainche, L, Sena-Esteves, Met al. (2008). Glioblastoma microvesicles transport RNA and proteins thatpromote tumour growth and provide diagnostic biomarkers. Nat Cell Biol10: 1470-1476.
6. Akao, Y, Iio, A, Itoh, T, Noguchi, S, Itoh, Y, Ohtsuki, Y et al. (2011). MicrovesiclemediatedRNA molecule delivery system using monocytes/macrophages. Mol Ther19: 395-399.
7. Kosaka, N, Iguchi, H, Yoshioka, Y, Takeshita, F, Matsuki, Y and Ochiya, T (2010).Secretory mechanisms and intercellular transfer of microRNAs in living cells. J BiolChem 285: 17442-17452.
8. Alvarez-Erviti, L, Seow, Y, Yin, H, Betts, C, Lakhal, S and Wood, MJ (2011). Delivery ofsiRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol29: 341-345.
9. Woodburn, JR (1999). The epidermal growth factor receptor and its inhibition incancer therapy. Pharmacol Ther 82: 241-250. (Pubitemid 29255919)
10. Li, Z, Zhao, R, Wu, X, Sun, Y, Yao, M, Li, J et al. (2005). Identification andcharacterization of a novel peptide ligand of epidermal growth factor receptor fortargeted delivery of therapeutics. FASEB J 19: 1978-1985. (Pubitemid 41759743)
11. Song, S, Liu, D, Peng, J, Sun, Y, Li, Z, Gu, JR et al. (2008). Peptide ligand-mediatedliposome distribution and targeting to EGFR expressing tumor in vivo. Int J Pharm363: 155-161.
12. Klutz, K, Schaffert, D, Willhauck, MJ, Gr?wald, GK, Haase, R, Wunderlich, Net al. (2011). Epidermal growth factor receptor-targeted (131)I-therapy of livercancer following systemic delivery of the sodium iodide symporter gene. Mol Ther19: 676-685.
13. Scher, A, Pahnke, A, Schaffert, D, van Weerden, WM, de Ridder, CM, Rl, W et al.(2011). Disconnecting the yin and yang relation of epidermal growth factor receptor(EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer systemavoiding receptor activation. Hum Gene Ther 22: 1463-1473.
14. Takamizawa, J, Konishi, H, Yanagisawa, K, Tomida, S, Osada, H, Endoh, H et al.(2004). Reduced expression of the let-7 microRNAs in human lung cancers inassociation with shortened postoperative survival. Cancer Res 64: 3753-3756. (Pubitemid 38697282)
15. Johnson, CD, Esquela-Kerscher, A, Stefani, G, Byrom, M, Kelnar, K, Ovcharenko, Det al. (2007). The let-7 microRNA represses cell proliferation pathways in human cells.Cancer Res 67: 7713-7722. (Pubitemid 47281364)
16. Boyerinas, B, Park, SM, Hau, A, Murmann, AE and Peter, ME (2010). The role of let-7in cell differentiation and cancer. Endocr Relat Cancer 17: F19-F36.
17. Lee, YS and Dutta, A (2007). The tumor suppressor microRNA let-7 represses theHMGA2 oncogene. Genes Dev 21: 1025-1030. (Pubitemid 46686471)
18. Ishida, T and Kiwada, H (2008). Accelerated blood clearance (ABC) phenomenonupon repeated injection of PEGylated liposomes. Int J Pharm 354: 56-62.
19. Simpson, RJ, Jensen, SS and Lim, JW (2008). Proteomic profiling of exosomes: currentperspectives. Proteomics 8: 4083-4099.
20. Murohashi, M, Hinohara, K, Kuroda, M, Isagawa, T, Tsuji, S, Kobayashi, S et al. (2010).Gene set enrichment analysis provides insight into novel signalling pathways in breastcancer stem cells. Br J Cancer 102: 206-212.
21. Oikawa, K, Ohbayashi, T, Kiyono, T, Nishi, H, Isaka, K, Umezawa, A et al. (2004).Expression of a novel human gene, human wings apart-like (hWAPL), is associatedwith cervical carcinogenesis and tumor progression. Cancer Res 64: 3545-3549. (Pubitemid 38657930)